Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Non-valvular Atrial Fibrillation

Interventions

DRUG

DU-176b 15mg

oral DU-176b 15mg once daily

DRUG

DU-176b 30mg

oral DU-176b 30mg once daily

DRUG

DU-176b 60mg

oral DU-176b 60mg once daily

Trial Locations (1)

Tokyo Women's Medical University Hospital, Tokyo